What You Need to Know
• Boston Scientific reported a cyberattack that disrupted its global operations, affecting order processing and shipping.
• The company discovered the incident on Tuesday and is working with cybersecurity experts to contain the threat.
• Boston Scientific’s shares dropped by as much as 6% in early trading following the announcement of the cyberattack.
Medical device manufacturer Boston Scientific announced on Wednesday that a cyberattack has disrupted its global operations, including critical systems for processing and shipping customer orders. The company identified the incident on Tuesday and is currently collaborating with external cybersecurity experts to investigate and mitigate the threat. In a securities filing, Boston Scientific indicated that the attack has caused ongoing disruptions to its information systems and business applications, with an uncertain timeline for full restoration. Following the news, shares of Boston Scientific fell by up to 6% in early trading. The healthcare sector is increasingly targeted by cybercriminals, with the industry accounting for 22% of disclosed attacks in 2025, according to cybersecurity firm BlackFog.
Why It Matters
This incident highlights the growing vulnerability of the healthcare sector to cyberattacks, which have become increasingly prevalent in recent years. Boston Scientific, a key player in medical technology, manufactures devices for heart health, cancer care, and gastrointestinal conditions. The disruption of its operations not only affects the company but also raises concerns about the broader implications for patient care and safety. As cyber threats continue to evolve, the need for robust cybersecurity measures in healthcare becomes even more critical.
Read the Full Story →
